[HTML] sciencedirect.com

[HTML][HTML] CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis

M Rodrigo-Faus, A Vincelle-Nieto, N Vidal, J Puente… - Cancer Letters, 2024 - Elsevier
Due to the limited effectiveness of current treatments, the survival rate of patients with
metastatic castration-resistant prostate cancer (mCRPC) is significantly reduced …
相关文章

CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis

M Rodrigo Faus, Á Vincelle-Nieto, N Vidal, J Puente… - 2024 - docta.ucm.es
Due to the limited effectiveness of current treatments, the survival rate of patients with
metastatic castrationresistant prostate cancer (mCRPC) is significantly reduced …

[引用][C] CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis

M Rodrigo-Faus, A Vincelle-Nieto… - Cancer …, 2024 - produccioncientifica.ucm.es

CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis

M Rodrigo-Faus, A Vincelle-Nieto, N Vidal… - Cancer … - pubmed.ncbi.nlm.nih.gov
Due to the limited effectiveness of current treatments, the survival rate of patients with
metastatic castration-resistant prostate cancer (mCRPC) is significantly reduced …

CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis.

M Rodrigo-Faus, A Vincelle-Nieto, N Vidal… - Cancer Letters, 2024 - europepmc.org
Due to the limited effectiveness of current treatments, the survival rate of patients with
metastatic castration-resistant prostate cancer (mCRPC) is significantly reduced …
[PDF] ucm.es

[PDF][PDF] CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis

M Rodrigo-Faus, A Vincelle-Nieto, N Vidal, J Puente… - Cancer Letters, 2024 - docta.ucm.es
Due to the limited effectiveness of current treatments, the survival rate of patients with
metastatic castrationresistant prostate cancer (mCRPC) is significantly reduced …